Advanced search×

Use of unregulated stem-cell based medicinal products.

Lancet 376(9740):514 (2010) PMID 20709228

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/S0140-6736(10)61249-4
Version: za2963e q8zac q8zb3 q8zc8 q8zd1 q8zec q8zf1 q8zg8
Buy PDF

Similar articles you may find interesting…

  1. Comparison of cell loading methods in hydrogel systems.
    Jinling Ma, Fang Yang, and Jeroen Jjp van den Beucken

    J Biomed Mater Res A (2013) PMID 23650286

    Bone regenerative medicine, based on the combined use of cells and scaffolds, represents a promising strategy in bone regeneration. Hydrogels have attracted huge interests for application as a scaffold for minimally invasive surgery. Collagen and oligo(poly(ethylene glycol)fumarate)...
    Buy PDF
  2. Engineering bone tissue substitutes from human induced pluripotent stem cells.
    Giuseppe Maria de Peppo, Iván Marcos-Campos, and Darja Marolt

    Proc Natl Acad Sci U S A (2013) PMID 23653480

    We first induced three hiPSC lines with different tissue and reprogramming backgrounds into the mesenchymal lineages and used a combination of differentiation assays, surface antigen profiling, and global gene expression analysis to identify the lines exhibiting strong osteogenic differentiation pot...
    Buy PDF
  3. In vitro biological and mechanical evaluation of various scaffold materials for myocardial tissue engineering.
    Florian E M Herrmann, Anja Lehner, and Bassil Akra

    J Biomed Mater Res A (2013) PMID 23650018

    We compared polyurethane, Collagen Cell Carriers, ePTFE and ePTFE SSP1-RGD regarding their receptiveness to seeding with mesenchymal stem cells isolated from umbilical cord tissue. Seeding was tested at an array of cell seeding densities. The bioartificial patches were cultured for up to 35 days and...
    Buy PDF